Cargando…
Clinical and Pathological Evolution of Giant Cell Arteritis: A Prospective Study of Follow-Up Temporal Artery Biopsies in 40 Treated Patients
While clinical signs and symptoms of giant cell arter it is improve promptly after starting glucocorticoid therapy, reports have suggested that the vascular inflammation may persist. To assess the duration and quality of his to pathologic changes in treated patients, we prospectively obtained second...
Autores principales: | Maleszewski, Joseph J., Younge, Brian R., Fritzlen, John T., Hunder, Gene G., Goronzy, Jorg J., Warrington, Kenneth J., Weyand, Cornelia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650068/ https://www.ncbi.nlm.nih.gov/pubmed/28256573 http://dx.doi.org/10.1038/modpathol.2017.10 |
Ejemplares similares
-
Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis
por: Ohtsuki, Shozo, et al.
Publicado: (2023) -
Innate and Adaptive Immunity in Giant Cell Arteritis
por: Akiyama, Mitsuhiro, et al.
Publicado: (2021) -
Giant cell arteritis: immune and vascular aging as disease risk factors
por: Mohan, Shalini V, et al.
Publicado: (2011) -
Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis
por: Ma-Krupa, Wei, et al.
Publicado: (2004) -
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
por: Jakobsson, Karin, et al.
Publicado: (2016)